Описание деятельности
Illumina is improving human health by unlocking the power of the genome. The company's focus on innovation has established us as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical and applied markets. Illumina's products are used for applications in the life sciences, oncology, reproductive health, agriculture and other emerging segments.
Правление & Наблюдательный совет
| Исполнительный директор |
| Jacob Thaysen, PhD |
| Правление |
| Ankur Dhingra, Steve Barnard, PhD, Nicole Berry, Todd Christian, Everett Cunningham, Scott Davies, Pat Leckman, Kevin Pegels, Carissa Rollins, Salli Schwartz, Bas Verhoef, Jakob Wedel, Gretchen Weightman, Jenny Zheng |
| Наблюдательный совет |
| Stephen P. MacMillan, Jacob Thaysen, PhD, Frances Arnold, PhD, Caroline Dorsa, Robert S. Epstein, Scott Gottlieb, Gary S. Guthart, Anna Richo, Philip Schiller, Sue Siegel, Scott B. Ullem |
Данные компании
| Имя: |
Illumina Inc. |
| Адрес: |
5200 Illumina Way,San Diego, California 92122, USA |
| Телефон: |
+1-858-202-4500 |
| Факс: |
+1-858-202-4766 |
| E-mail: |
info@illumina.com
|
| Интернет: |
www.illumina.com/ |
| Индустрия: |
Healthcare |
| Сектор: |
Medical Products |
| Подсектор: |
Advanced Medical Devices |
| Конец финансового года: |
31.12 |
| Акции в свободном обращении: |
48.29% |
| Дата IPO: |
28.07.2000 |
Связи с инвесторами
| Имя: |
- |
| IR телефон: |
+1-858-291-6421 |
| IR-факс: |
- |
| IR e-mail: |
ir@illumina.com
|
